HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the ...

Discover how understanding your viral load and CD4 count puts you in control of HIV treatment and transforms confusing ...

Immunologists at UNIGE have revealed a previously unknown anti-tumor role of CD4 T lymphocytes, marking a breakthrough that ...

The Johns Hopkins team that conducted the new study had previously shown that the molecule of interest, an “antisense ...

When it comes to a clinical study to evaluate the therapeutic effect of Shivagutika treatment in patients with HIV, it was ...

Creating a Promising and Novel Molecule In their research, Professor Gauthier's team studied two natural molecules: betulinic ...

There are two ways that HIV patients’ bodies can keep the virus under control after they stop antiretroviral therapy, a new ...

Gene therapy may be a crucial tool to put HIV to sleep permanently, providing a lasting and durable treatment against the v ...

Incomplete immune recovery despite sustained virologic suppression in patients with HIV was associated with increased risk for incident cancer.

Whether antiretroviral therapy (ART) is always completely suppressive, or HIV might continue to replicate at low levels despite ART in some people with HIV (PWH), is still debated. Here, we ...

A new nanozyme-powered TB test improves detection in people with HIV, offering rapid, electricity-free diagnosis via a beetle-inspired chip.

The Tulane team has developed a handful of other assays for TB detection, including mass spec test for paucibacillary TB that is being commercialized by Nanopin Tech, and a non-sputum CRISPR-based lab ...